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Abstract
Objective—Complement system is activated in patients with trauma. Although complement
activation is presumed to contribute to organ damage and constitutional symptoms, little is known
about the involved mechanisms. Because complement components may deposit on red blood cells
(RBC), we asked whether complement deposits on the surface of RBC in trauma and whether such
deposition alters RBC function.
Design—A prospective experimental study
Setting—Research laboratory
Subjects—Blood samples collected from 42 trauma patients and 21 healthy donors
Intervention—None
Measurements and Main Results—RBC and sera were collected from trauma patients and
control donors. RBC from trauma patients (n=40) were found to display significantly higher
amounts of C4d on their surface by flow cytometry compared to normal RBC (n=17) (P<0.01).
Increased amounts of iC3b were found in trauma sera (n=27) (vs. 12 controls, P<0.01) by ELISA.
Incubation of RBC from universal donors (O,Rh-) with trauma sera (n=10) promoted C4d
deposition on their surface (vs. 6 controls, P<0.05). Complement-decorated RBC (n=6) displayed
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limited their deformability (vs. 6 controls, P<0.05) in 2-dimensional microchannel arrays.
Incubation of RBC with trauma sera (n=10) promoted the phosphorylation of band 3, a
cytoskeletal protein important for the function of the RBC membrane (vs. 8 controls, P<0.05), and
also accelerated calcium influx (n=9) and enhanced nitric oxide production (n=12) (vs. 4 and 8
controls respectively, P<0.05) in flow cytometry.
Conclusions—Our study found the presence of extensive complement activation in trauma
patients and presents new evidence in support of the hypothesis that complement activation
products deposit on the surface of RBC. Such deposition could limit RBC deformability and
promote the production of nitric oxide. Our findings suggest that RBC in trauma patients
malfunction, which may explain organ damage and constitutional symptoms that is not accounted
for otherwise by previously known pathophysiologic mechanisms.
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Introduction
The clinical significance of trauma cannot be underestimated with over 10 million car
accidents occurring and over 35 thousand people dying each year in the U.S. (1). Trauma
resulting from accidents or unintentional injuries is the first leading cause of death for those
under 50 years old and accounts for one out of about every 20 deaths in the U.S. (2).
Although trauma usually involves a certain anatomical injury involving extremities or the
torso and is followed by obvious pathophysiological events usually linked to blood loss, it is
invariably associated with manifestations from organs not directly affected by injury. The
origin of these secondary manifestations is poorly understood. There is information
suggesting the presence of an acute inflammatory response in patients experiencing trauma.
Specifically, there is evidence that complement system is activated and mediates early post-
traumatic inflammatory response (3-5). In addition, the levels of proinflammatory cytokines,
including TNF-á, IL-1 and IL-6 are increased in trauma (6, 7). It is suggested that
complement activation and proinflammatory cytokine storm occurring in patients with
trauma collectively choreograph systemic inflammatory response syndrome associated with
acute respiratory distress syndrome and multiple organ failure (8).
In other situations where complement is profusely activated, such as in systemic lupus
erythematosus (SLE), complement fragments deposit on the surface of red blood cells
(RBC), which limits their deformability while promoting nitric oxide (NO) production (9). It
has been reported that RBC from patients suffering from hemorrhagic shock displays
reduced deformability, show altered morphological appearance, and contribute to the
reduction of blood flow to distant organs (10, 11).
Based on the evolving studies, we hypothesized that complement activation affects RBC
function in trauma patients. In this communication we demonstrate that complement
becomes activated in trauma patients and split products are deposited on the surface of RBC
limiting their ability to pass through capillary-size microchannels and increasing their
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capacity to produce NO. Our findings suggest that the inhibition of complement can serve as
an adjunct treatment in trauma patients.
Materials and Methods
Participants
This prospective experimental study was approved by the institutional Review Board of
Beth Israel Deaconess Medical Center, and was carried out as anonymized wasted samples
under a waiver of consent. Total of 42 patients who visited the emergency room at Beth
Israel Deaconess Medical Center for trauma from July 2012 to March 2013 were enrolled
nonconsecutively. Trauma patients were 18 years and older, and have been admitted for
bone fracture, organ injury or head trauma. They received a blood test as required for their
care. Patients carrying the diagnosis of cancer, infection, or autoimmune diseases were
excluded. None of the patients had received a transfusion prior to sampling. Healthy donors
(n=21) were recruited from the Division of Rheumatology at Beth Israel Deaconess Medical
Center after written informed consent. They did not have an apparent illness. RBC were
collected from 40 out of 42 trauma patients (2 samples were destroyed during the sample
collection process) and 17 healthy donors and sera were collected from 27 patients and 13
healthy donors. Patients’ clinical data were recorded including age, sex, ethnicity,
mechanism of injury, and existing injury. Injury Severity Score (ISS) was also calculated.
Antibodies and reagents
Primary antibodies were anti-C4d monoclonal antibody (A213; Quidel, San Diego, CA) and
IgG1k-isotype control (401402; BioLegend, San Diego, CA). Secondary antibody was
Alexa Fluor 488-conjugated rabbit anti-mouse IgG (A11059; Life technologies, Grand
Island, NY). Other reagents were as follows: Hanks’ balanced salt solution with Ca2+ and
Mg2+ (HBSS++) (14025; Life technologies), IgG-free bovine serum albumin (BSA) (A9085;
Sigma-Aldrich, St Louis, MO), DAF-FM diacetate (D23844; Life technologies), Flio-4 AM
(F14217; Life technologies), and eosin-5-maleomide (E118; Life technologies).
Measurement of serum iC3b levels
The concentration of iC3b present in serum was measured using the MicroVue iC3b
Enzyme Immunoassay kit (A006; Quidel)
RBC preparation and incubation with sera
Heparinized blood or serum of trauma patients was obtained from the Emergency
Department after clinical examination, and control blood or serum was obtained from
healthy adult volunteers. The sample collection was performed in accordance with
guidelines of the Institutional Review Board of Beth Israel Deaconess Medical Center after
informed consent in accordance with the Declaration of Helsinki. Blood was collected in
heparin-lithium tubes for RBC and serum in serum-separator tubes. The serum was stored at
−80°C. Heparinized blood was washed in HBSS++ before use.
For serum studies, on the day of the experiment, the serum samples were thawed from
various trauma patients and healthy donors and were used for different measurements under
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the same conditions. Blood from healthy universal donors (type O, Rh negative) was
obtained in heparin-lithium tube and washed with HBSS++. One μl of RBC pellet was
resuspended in 80 μl of HBSS++, and incubated with 20 μl of serum from trauma patients or
normal donors for 15 minutes at 37°C, and then washed in HBSS++ with 0.5% IgG-free
BSA (0.5%BSA/HBSS++).
Flow cytometry
RBC were incubated for 20 minutes with a primary antibody in 0.5%BSA/HBSS++ at room
temperature, washed and incubated for another 20 minutes with a secondary antibody
directed against the primary antibody at a dilution recommended by the manufacturer. RBC
were then, washed and analyzed by FACScan (BD Biosciences, San Jose, CA). At least
10,000 events in each sample were acquired and recorded, and analyzed by FlowJo (version
7.6.5 software; Tree Star, Ashland, OR).
Eosin-5-maleimide staining
RBC from healthy universal donors were incubated in the presence of Ca2+ and Mg2+ with
20% trauma or control sera for 5 minutes at 37°C, and then incubated for 15 min with
eosin-5-maleimide at a final concentration of 0.1 mg/ml. RBC then were washed 3 times
with HBSS++ and 0.5%BSA/HBSS++ and analyzed by flow cytometry.
Analysis of intracellular calcium influx
RBC from healthy universal donors were preloaded with Fluo-4 AM for 15 minutes at 37°C,
then, washed to remove any dye that is nonspecifically bound with RBC surface, and
resuspended in HBSS++. Loaded RBC were incubated at room temperature for an additional
10 minutes to allow complete de-esterification of intracellular AM esters. Fluorescence
levels of RBC were acquired by FACScan for establishing the baseline of intracellular Ca2+
concentration. After 60 seconds, one hundred microliters of control or trauma serum was
quickly added to the RBC (20% of final concentration), and the change of the fluorescence
intensity that indicates intracellular Ca2+ concentration was recorded for an additional 3
minutes.
Measurement of NO production
RBC from healthy universal donors preloaded with DAF-FM diacetate in BSA-free HBSS++
for 30 minutes at 37°C, were washed to remove excess and un-cleaved intracellular DAF-
FM diacetate probe. Cells were then resuspended in HBSS++ with 20% trauma or control
serum for 15 minutes at 37°C. RBC were washed and the fluorescence intensity associated
with intracellular NO production was recorded by FACScan using the FL-1 channel.
Measurement of RBC deformability using 2-dimensional (2-D) filters
To measure the ability of RBC to undergo capillary-like deformations, we used a 2-D
microchannel array as previously described (12) that uses the hydrostatic pressure to drive
the RBC through the microchannel array. For each experiment, the device was calibrated
using as reference the zero pressure difference corresponded to the absence of movement of
RBC within the device. RBC (8 μl, hematocrit 20%) were loaded into the inlet reservoir and
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driven into the capillary-like area by lowering the waste reservoir tubing. Once RBC entered
the capillary-like area, the waste reservoir tubing was raised at a height that allowed RBC to
pass through the 25-μm length of the capillary in about 3 seconds. The cells were recorded
using a 40x0.75 Ph2 Plan Fluorite objective on a TE300 Nikon inverted microscope (Nikon
Inc., Melville, NY), using a Retiga Exi (QImaging, Surrey, Canada) CCD camera controlled
with iVision 4.7 software (BioVison, Exton, PA) at a rate of 10 frames/second. Movies
representing 600 frames then were analyzed off-line frame by frame, and the results were
expressed as the number of seconds from entry to egress (9). RBC that displayed unusual
shapes (e.g. echinocytes, acanthocytes) were excluded from the measurement.
Statistical analysis
SPSS version 17.0 for Windows (SPSS, Chicago, IL) was used for all statistical analysis.
Mann-Whitney U test was used for between group analysis and values were showed as
medians [interquartile range] unless otherwise stated. Correlation between the ISS and the
amount of C4d deposition on trauma RBC was assessed by Spearman correlation
coefficient. Paired t-test analysis was performed wherever necessary. A value of P< 0.05
was considered statistically significant.
Results
Patient characteristics
A total of 42 patients were included in this study (Table 1). The patient group consisted of
33 men, and 9 women, with mean age of 47 years. Most of the patients presented with blunt
injury resulting from motor vehicle crash (n=19) or fall (n=16). The median value of ISS
was 17 [9-25].
Deposition of complement activated product C4d on RBC from trauma patients
To determine the extent of complement deposition on the surface of RBC of trauma patients,
we used 40 samples from trauma patients and 17 samples from healthy donors. RBC from
trauma patients displayed significant C4d deposition on their membrane as compared to
RBC from normal healthy donor (565 [443-886] versus 386 [309-489], P<0.01, Table 2). A
representative tracing is shown in Figure 1A and cumulative data in Figure 1B. We did not
find a correlation between the ISS and the amount of C4d deposited on the surface of RBC
(data not shown).
It has been reported previously that complement becomes activated in patients who suffer
various forms of trauma (4, 13). To confirm that complement activation occurred in our
trauma patients we measured the iC3b levels in the sera obtained from trauma patients and
healthy donors. Indeed, iC3b levels were significantly higher in the sera of trauma patients
(n=27) compared to sera from healthy donors (n=12) (10.7 [8.2-14.0] versus 6.6 [5.3-9.4]
P<0.01) (Figure 1C).
C4d deposition on healthy RBC incubated with sera from trauma patients
In order to evaluate the effect of complement deposition on various aspects of RBC
function, we first established a method to show that incubation of normal RBC from
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universal donors (type O, Rh negative) with sera from trauma patients results in complement
deposition on the surface of RBC. Indeed, as shown in Figure 2A (representative
experiment) and Figure 2B (cumulative data), incubation of normal RBC with sera from
trauma patients (n=10) resulted in a significant C4d deposition on the membrane of RBC as
compared to sera from healthy controls (n=6) (289 [282-300] versus 267 [261-272],
P<0.05). Removal of Ca2+ by adding 10mM EDTA to the serum decreased the deposition of
C4d on the surface of RBC (Figure 2C), suggesting that activation of complement through
the classical pathway accounts for the deposition of complement on RBC (14).
Decreased RBC membrane deformability by trauma sera
It has been previously reported that complement deposition on RBC can render their
membrane less deformable, limiting the ability of RBC to pass through capillaries (15). We
evaluated RBC membrane deformability by using a microfluidic device as described in the
Materials and Methods section (Figure 3A) and measured the time it took RBC to pass
through the microchannels. RBC from a universal donor were treated either with sera from
normal individuals (n=6) or trauma patients (n=6). Individual dot blots are presented in
Figure 3B and cumulative data in Figure 3C. Our results show that exposure of RBC to sera
from trauma patients limits their ability to pass through capillary-size microchannels (2.03
[1.96-2.25] versus 1.85 [1.81-1.90], P<0.05).
Phosphorylation status of band 3
RBC membrane deformability is related to the phosphorylation status of membrane proteins
such as β-spectrin or band 3 (16, 17). To determine whether band 3 becomes phosphorylated
in RBC exposed to trauma sera, we treated RBC exposed to control (n=8) or trauma sera
(n=10) with eosin-5-maleimide, a reagent which binds to lysine 430 on the extracellular loop
of band 3 and is known to indicate tyrosine phosphorylation levels (17). Binding of eosin-5-
maleimide to RBC has been used previously to estimate the phosphorylation levels of band
3 (9, 17), and here we similarly used eosin-5-maleimide to estimate the tyrosine
phosphorylation levels of band 3. As shown in Figure 4, band 3 of RBC was phosphorylated
after incubation with trauma sera compared to incubation with normal sera (89.3 [88.3-92.3]
versus 84.8 [83.0-85.5], P<0.05).
Promotion of Ca2+ influx
Tyrosine phosphorylation level of band 3 is known to correlate with intracellular Ca2+
concentration (18, 19). We asked whether exposure of RBC to trauma sera results in
increased Ca2+ entry. As shown in Figure 5A (representative tracings) and Figure 5B
(cumulative data), the addition of trauma sera (n=9) to Fluo-4 AM- loaded RBCs resulted in
increased Ca2+ concentrations into the RBC compared to RBC to which normal sera (n=4)
were added (1.08 [1.05-1.12] versus 1.03 [1.02-1.04], P<0.05).
Induction of the NO production
Recently, it was reported that human RBC express an active and functional endothelial-type
NO synthase (eNOS) which is present in the membrane and in the cytoplasm (20). In RBC,
mechanical stress (shear stress) stimulates NO generating mechanisms and Ca2+ is important
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in this process (21). Having observed that exposure of RBC to trauma serum results in
increased intracellular Ca2+ concentrations, we asked whether it also results in an increased
NO production. Our results showed that exposure of RBC to trauma sera (n=12) promoted
NO production compared to exposure to normal sera (n=8) (543 [527-576] versus 453
[425-501], P<0.05) (Figure 6A, representative tracing, and Figure 6B, cumulative data).
Increased NO production results from the deposition of complement on the surface of RBC
because heat inactivation of sera (55°C for 30 minutes) eliminated the ability of trauma sera
to increase NO production by RBC (Figure 6C) (597±59 versus 521±21, mean±SD, paired t-
test, P<0.05).
Discussion
Complement becomes activated in patients suffering various types of trauma and this was
confirmed in our patients by demonstrating increased levels of iC3b in their sera.
Uncontrolled complement activation, common in a wide-variety of conditions both chronic
and acute, has multiple deleterious effects on various circulating blood cells as well as on
organ function primarily through the action of inflammatory split products (anaphylatoxins)
such as C3a and C5a (22, 23). To date, there is little data regarding the effects of the non-
inflammatory complement by-products, mainly C3b and C4b generated during complement
activation on circulating cell function, specifically RBC. In this study we show that C4d, a
split product of C4, deposits on the surface of RBC, thus limiting their ability to pass
through narrow microchannels and enhancing NO production. These functional effects are
likely due to the fact that C4d deposition on the surface of RBC promotes a significant RBC
Ca2+ influx that mediates phosphorylation of band 3.
C4d is the stable remnant of C4 and it has been shown to remain on the surface of RBC in
patients with SLE for a prolonged period of time (24, 25). In our study, we demonstrated
increased deposition of C4d on the surface of RBC from patients with various degrees and
types of trauma; yet, we failed to demonstrate a direct correlation between ISS determined
clinically and levels of C4d deposition on the surface of RBC. One possible explanation we
were not able to establish the correlation is the logistics involved in handling trauma patients
and the collection of blood or sera samples. The time that lapsed between trauma and the
collection of samples could not be controlled, which could have affected the overall amounts
of C4d that had accumulated on the surface of RBC.
Following the two key observations- the increased complement activation in sera and
increased deposition of complement fragment C4d on RBC in trauma patients- we chose to
test whether the increase in complement activation and deposition leads to RBC dysfunction.
Should binding of complement on the surface of RBC have a functional effect, it should be
occurring at early time points. To explore this, RBC from universal donors were incubated
with sera from trauma patients who showed enhanced deposition of C4d on RBC. As noted,
exposure of RBC to trauma serum resulted in limitation of their ability to pass through
capillaries, increased phosphorylation of band 3, Ca2+ entry, and NO production. The
alterations in RBC function in trauma patients could be due to deposition of complement
fragments on the RBC membranes as others and we have shown both in vitro and ex vivo
using RBC from normal individuals (15) and SLE patients (9).
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The functional consequences of the deposition of complement on the surface of RBC cannot
be overstated. In order for RBC to perform their main function, that is to deliver oxygen to
tissues, they must pass through narrower (<8 μm in diameter) capillaries and to do that they
have to be able to deform (26, 27). If deposition of C4d renders them difficult to deform and
reach tissues, then hypoxia will ensue. During normal conditions, RBC-generated NO is a
key factor in the local regulation of vasomotor tone and microvascular flow resistance, by
interacting directly with endothelial cells and indirectly with vascular smooth muscles (28).
In addition, NO derived from eNOS present in RBC also directly regulates and maintains
RBC deformability (20, 29). In our study we demonstrated that under trauma conditions,
increased complement deposition decreases RBC deformability and increases NO
production. According to the existing literature, under normal conditions, increase in NO
production improves microvascular blood flow. However in our studies, although the NO
production is high in trauma patients, we observe a decrease in RBC deformability. We
speculate that this may be due to C4d deposition on RBC in trauma patients that may have a
prominent effect on RBC deformability than compared to NO effect on RBC deformability.
The increased production of NO by C4d-decorated RBC in the microcirculation may further
alter epithelial and smooth muscle cell function and influence the clinical picture in trauma
patients.
Our studies have certain limitations including the fact that the studied cohort was quite
diverse. While we limited the effect of important comorbidities by excluding patients with
significant comorbidities from the study, the data about plausible confounding variables
such as smoking, substance abuse, and medications were not collected. In addition, we were
unable to recruit exact age-, ethnicity-, and sex- matched healthy individuals, and hence
these parameters show differences between trauma and control groups. Further studies need
to be done in clinically homogenous trauma patients compared to matched controls. The
second limitation is that although we made every effort to minimize the time between the
collection of the blood sample and the performance of the experiments, we could not control
the time between the occurrence of traumatic injury and the time the patient was admitted to
the emergency room. As indicated above, during that time, variable amounts of C4d could
have been deposited on the surface of RBC. Yet, the studies in which RBC from universal
donors were exposed to trauma serum collected and stored properly lend validity to our
conclusions. A proper prospective study (e.g. collection of serial blood samples from trauma
patients during the first hours or days after admission) should be more informative. Third,
for the serum-based experiments, instead of whole study sample, we used sera from trauma
patients who showed increased C4d deposition on RBC. In the current study, our goal was to
narrow down our experimental design from an epidemiologic standpoint to a proof-of
concept study to further understand the molecular mechanisms.
Conclusions
We conclude that C4d decorates the surface of RBC and possibly limits their ability to
deform and pass through capillary-size microchannels and increases the production of NO.
Thus it may contribute to trauma-associated morbidity and mortality. As a next step, we plan
to conduct a prospective study with larger population, which includes clinically homogenous
trauma patients compared to matched controls. We believe that our present and future
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findings might suggest modalities that limit complement activation in trauma patients to be
considered for clinical trials.
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Figure 1. Increased C4d deposition on the surface of membrane of red blood cells from trauma
A, Deposition of C4d on the surface of red blood cells from trauma patients and healthy
donors was measured by flow cytometry. Representative of experiments is shown.
B, Data of C4d deposition on red blood cells from all samples was expressed as mean
fluorescence intensity and cumulative data from trauma patients (n=40) or normal healthy
donors (n=17) are shown as box plots. Each box shows the 25th and 75th percentiles. Lines
outside the boxes show the lowest and the highest values. Lines inside the boxes show the
median.
C. Serum levels of iC3b fragments from trauma patients (n=27) and from normal healthy
donors (n=12) were assayed as a measure of activation of complement. Horizontal lines
indicate the median.
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Figure 2. Increased C4d deposition on healthy red blood cell membranes incubated with trauma
sera
A. Deposition of C4d on the surface of healthy red blood cells (type O, Rh negative)
incubated with sera from trauma patients or healthy donors were measured by flow
cytometry. Representative data is shown.
B. Data of C4d deposition on red blood cells from all samples was expressed as mean
fluorescence intensity, and cumulative data from trauma patients (n=10) or healthy donors
(n=6) are shown as box plots. Each box shows the 25th and 75th percentiles. Lines outside
the boxes show the lowest and the highest values. Lines inside the boxes show the median.
C. Deposition of C4d on the surface of healthy red blood cells (type O, Rh negative)
incubated with sera from trauma patients with or without 10 mM EDTA. Representative
data is shown.
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Figure 3. Decreased red blood cell membrane deformability after incubation with trauma sera
A. A composite series of images illustrating the passage of a single red blood cell through a
capillary-size microchannel of the 2- dimensional filter device
B. Healthy universal donor's (type O, Rh negative) red blood cells deformability were
measured by using the 2-dimensional filter device after incubation with sera from trauma
patients or healthy donors. Decreased deformability of each red blood cell was associated
with increased transit time (i.e. the time it took the cell to pass through the capillary
microchannels of 2-dimensional filter). Data are shown as dot blots of all experiments with
each circle showing the passage time for one red blood cell. Horizontal lines show the mean.
Representative data are shown.
C. Cumulative data from trauma patients (n=6) or healthy donors (n=6) are shown. Data are
expressed as box plots. Each box shows the 25th and 75th percentiles. Lines outside the
boxes show the lowest and the highest values. Lines inside the boxes show the median.
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Figure 4. Phosphorylation status of band 3 in red blood cells incubated with trauma sera
Phosphorylation of band 3 in healthy red blood cells (type O, Rh negative) measured by
flow cytometry after incubation with sera from trauma patients or healthy donors, using
eosin-5-maleimide staining. Band 3 phosphorylation was expressed as mean fluorescence
intensity of eosin-5-maleimide fluorescence, and cumulative data from trauma patients
(n=10) or healthy donors (n=8) are shown as box plots. Each box shows the 25th and 75th
percentiles. Lines outside the boxes show the lowest and the highest values. Lines inside the
boxes show the median.
Muroya et al. Page 17
Crit Care Med. Author manuscript; available in PMC 2015 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. Ca2+ influx into red blood cell after addition of trauma sera
A, Time course of serum-induced changes in intracellular Ca2+ of trauma patients (Tr4 and
Tr5) or a healthy control (N3) are shown. Arrow indicates the time when trauma or control
sera were added to red blood cell preloaded with Fluo-4 AM, 1 minute after start of
measurement by flow cytometry. Vertical axis indicates relative intracellular Ca2+
concentration, which is estimated from mean fluorescence intensity of Fluo-4 AM.
Representative data are shown.
B. Cumulative results of Ca2+ influx in red blood cells to which trauma sera (n=9) or normal
sera (n=4) were added. Vertical axis shows the ratio of mean fluorescence intensity of
Fluo-4 AM before and after adding the serum. Horizontal lines indicate the median.
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Figure 6. Nitric oxide production from red blood cells induced by trauma serum
A. Nitric oxide production from healthy red blood cells (type O, Rh negative) measured by
flow cytometry after incubation with sera from trauma patients or healthy donors by using
DAF-FM diacetate. Representative data is shown.
B. Nitric oxide production from red blood cells was expressed as mean fluorescence
intensity of DAF-FM diacetate fluorescence, and cumulative data from trauma patients
(n=12) or healthy donors (n=8) are shown as box plots. Each box shows the 25th and 75th
percentiles. Lines outside the boxes show the lowest and the highest values. Lines inside the
boxes show the median.
C. Heat inactivation of complement in sera from trauma patients eliminates their ability to
trigger NO production. To inactivate complement, sera were incubated 55°C for 30 minutes.
Red blood cells were incubated with sera from trauma patients before or after inactivation of
complement. Individual sera with/without inactivation of complement are shown. Straight
lines are used to connect individual points to help visualize how different they are in each
sample (n=4).
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Table 1
Patients Demographics
Demographic data n=42
Age, mean (±SD), y 46.5 (±19.6)
Sex(m/f) 33/9
Ethnicity, n(%)
White 37(88)
Black 2(5)
Hispanic 1(2)
Other 2(5)
Mechanism of Trauma, n(%) n=42
MVC 19(45)
Fall 16(38)
PS 1(2)
Other 6(14)
Organ injury, n(%)
Bone Fracture 33(79)
Head 9(21)
Lung 7(17)
Spleen 5(12)
Intestine 3(7)
Liver 0(0)
Kidney 0(0)
Other 1(2)
Type of Bone fracture, n
Femur 11
Tibia or Fibula 10
Spine 9
Rib 9
Radius or Ulna 6
Humerus 3
Hip 1
Other 21
Operative procedure, n
Orthopedic surgery 23
Thoracic surgery 4
ISS, mean (±SD) 19.6 (±12.6)
MVC: motor vehicle crash, PS: pedestrian struck, ISS: Injury Severity Score, SD: standard deviation
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Table 2
Patient Demographics of C4d deposition on trauma red blood cell
Trauma Patients n=40 Healthy Controls n=17 P value(Mann-Whitney U testa,
Fisher's Exact Testb)
Age, median (interquartile range), y 47 (31-50) 36(34-38) 0.32a
Ethnicity, White, n (%) 36 (90) 10(59) 0.011b
Sex, male, n (%) 31 (78) 10(59) 0.13b
MFI of C4d level , median (interquartile range) 565(443-886) 386(309-489) <0.01a
MFI: mean fluorescence intensity
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